Your browser doesn't support javascript.
loading
Preparation and characterization of a high-affinity monoclonal antibody against human epididymis protein-4.
Shen, Yunlong; Wang, Yuxi; Jiang, Xiaohua; Lu, Liang; Wang, Chengdi; Luo, Wenxin; Zhang, Yongxia; Li, Pei; Du, Zhengwei; Dai, Tengfei; Wu, Congcong; Fang, Aiping; Yao, Yuqin; Peng, Qian; Yang, Jinliang.
Afiliação
  • Shen Y; Research Center for Public Health and Preventive Medicine, West China School of Public Health/No.4 West China Teaching Hospital, Sichuan University, Chengdu, 610041, PR China; Lab of Genetically Engineered Antibody, Cancer Center, West China Medical School, West China Hospital, Sichuan University, C
  • Wang Y; Lab of Genetically Engineered Antibody, Cancer Center, West China Medical School, West China Hospital, Sichuan University, Chengdu, PR China. Electronic address: wangyuxi198853@foxmail.com.
  • Jiang X; Lab of Genetically Engineered Antibody, Cancer Center, West China Medical School, West China Hospital, Sichuan University, Chengdu, PR China. Electronic address: 1258758932@qq.com.
  • Lu L; R & D Department of AtaGenix Laboratories Co., Ltd. (Wuhan), Wuhan, PR China. Electronic address: llu@atagenix.com.
  • Wang C; Department of Respiratory Medicine, West China Hospital of Sichuan University, No. 37, Guo Xue Street, Chengdu, Sichuan, 610041, PR China. Electronic address: chengdi_wang@stu.scu.edu.cn.
  • Luo W; Department of Respiratory Medicine, West China Hospital of Sichuan University, No. 37, Guo Xue Street, Chengdu, Sichuan, 610041, PR China. Electronic address: wenxin8905@163.com.
  • Zhang Y; R & D Department of AtaGenix Laboratories Co., Ltd. (Wuhan), Wuhan, PR China. Electronic address: yzhang@atagenix.com.
  • Li P; R & D Department of AtaGenix Laboratories Co., Ltd. (Wuhan), Wuhan, PR China. Electronic address: pli@atagenix.com.
  • Du Z; R & D Department of AtaGenix Laboratories Co., Ltd. (Wuhan), Wuhan, PR China. Electronic address: zwdu@atagenix.com.
  • Dai T; R & D Department of AtaGenix Laboratories Co., Ltd. (Wuhan), Wuhan, PR China. Electronic address: tfdai@atagenix.com.
  • Wu C; R & D Department of AtaGenix Laboratories Co., Ltd. (Wuhan), Wuhan, PR China. Electronic address: ccwu@atagenix.com.
  • Fang A; Research Center for Public Health and Preventive Medicine, West China School of Public Health/No.4 West China Teaching Hospital, Sichuan University, Chengdu, 610041, PR China; Lab of Genetically Engineered Antibody, Cancer Center, West China Medical School, West China Hospital, Sichuan University, C
  • Yao Y; Research Center for Public Health and Preventive Medicine, West China School of Public Health/No.4 West China Teaching Hospital, Sichuan University, Chengdu, 610041, PR China; Lab of Genetically Engineered Antibody, Cancer Center, West China Medical School, West China Hospital, Sichuan University, C
  • Peng Q; Cancer Center, Hospital of the University of Electronic Science and Technology of China, Sichuan Provincial People's Hospital, Chengdu 610072, Sichuan, PR China. Electronic address: pengqian0522@163.com.
  • Yang J; Lab of Genetically Engineered Antibody, Cancer Center, West China Medical School, West China Hospital, Sichuan University, Chengdu, PR China. Electronic address: jlyang01@163.com.
Protein Expr Purif ; 141: 44-51, 2018 Jan.
Article em En | MEDLINE | ID: mdl-28928083

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Proteínas / Anticorpos Monoclonais Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: Protein Expr Purif Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Proteínas / Anticorpos Monoclonais Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: Protein Expr Purif Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2018 Tipo de documento: Article